| [1] | World Health Organization (2007) Tuberculosis Fact Sheet. Fact Sheet No. 104. Available: http://www.who.int/mediacentre/factsheet？s/fs104/en/print.html. Accessed 25 September 2007.
|
| [2] | Banyai A (1931) Diabetes and pulmonary tuberculosis. Am Rev Tuberc 24: 650–667.
|
| [3] | Root H (1934) The association of diabetes and tuberculosis. New Engl J Med 210: 1–13.
|
| [4] | Boucot KR, Dillon ES, Cooper DA, Meier P, Richardson R (1952) Tuberculosis among diabetics: the Philadelphia survey. Am Rev Tuberc 65: 1–50.
|
| [5] | Nichols GP (1957) Diabetes among young tuberculous patients; a review of the association of the two diseases. Am Rev Tuberc 76: 1016–1030.
|
| [6] | Silwer H, Oscarsson PN (1958) Incidence and coincidence of diabetes mellitus and pulmonary tuberculosis in a Swedish county. Acta Med Scand Suppl 335: 1–48.
|
| [7] | Kim SJ, Hong YP, Lew WJ, Yang SC, Lee EG (1995) Incidence of pulmonary tuberculosis among diabetics. Tuber Lung Dis 76: 529–533.
|
| [8] | Pablos-Mendez A, Blustein J, Knirsch CA (1997) The role of diabetes mellitus in the higher prevalence of tuberculosis among Hispanics. Am J Public Health 87: 574–579.
|
| [9] | Ponce-De-Leon A, Garcia-Garcia Md Mde L, Garcia-Sancho MC, Gomez-Perez FJ, Valdespino-Gomez JL, et al. (2004) Tuberculosis and diabetes in southern Mexico. Diabetes Care 27: 1584–1590.
|
| [10] | Alisjahbana B, van Crevel R, Sahiratmadja E, den Heijer M, Maya A, et al. (2006) Diabetes mellitus is strongly associated with tuberculosis in Indonesia. Int J Tuberc Lung Dis 10: 696–700.
|
| [11] | Perez A, Brown HS 3rd, Restrepo BI (2006) Association between tuberculosis and diabetes in the Mexican border and non-border regions of Texas. Am J Trop Med Hyg 74: 604–611.
|
| [12] | Oluboyo PO, Erasmus RT (1990) The significance of glucose intolerance in pulmonary tuberculosis. Tubercle 71: 135–138.
|
| [13] | Basoglu OK, Bacakoglu F, Cok G, Sayiner A, Ates M (1999) The oral glucose tolerance test in patients with respiratory infections. Monaldi Arch Chest Dis 54: 307–310.
|
| [14] | World Health Organization (2006) Diabetes fact sheet No. 312. Available: http://www.who.int/mediacentre/factsheet？s/fs312/en/index.html. Accessed 12 March 2008.
|
| [15] | Restrepo BI (2007) Convergence of the tuberculosis and diabetes epidemics: Renewal of old acquaintances. Clin Inf Dis 45: 436–438.
|
| [16] | Stevenson CR, Forouhi NG, Roglic G, Williams BG, Lauer JA, et al. (2007) DM and tuberculosis: the impact of the DM epidemic on tuberculosis incidence. BMC Public Health 7: 234.
|
| [17] | Dixon B (2007) Diabetes and tuberculosis: an unhealthy partnership. Lancet Infect Dis 7: 444.
|
| [18] | Wild S, Sicree R, Roglic G, King H, Green A (2004) Global prevalence of diabetes: Estimates for the year 200 and projections for 2030. Diabetes Care 27: 1047–1053.
|
| [19] | WHO (2007) Global tuberculosis control: surveillance, planning, financing. WHO report 2007. WHO/HTM/TB/2007.376. Geneva: WHO. Available: http://www.who.int/tb/publications/globa？l_report/2007/en/index.html. Accessed 10 June 2008.
|
| [20] | Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, et al. (2000) Meta-analysis of observational studies in epidemiology: A proposal for reporting. JAMA 283: 2008–2012.
|
| [21] | Cochran WG (1954) The combination of estimates from different experiments. Biometrics 10: 101–129.
|
| [22] | Higgins JP, Thompson SG (2002) Quantifying heterogeneity in meta-analyses. Stat Med 21: 1539–1558.
|
| [23] | DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177–188.
|
| [24] | Greenland S, Thomas DC (1982) On the need for the rare disease assumption in case-control studies. Am J Epidemiol 116: 547–553.
|
| [25] | Dyck RF, Klomp H, Marciniuk DD, Tan L, Stang MR, et al. (2007) The relationship between diabetes and tuberculosis in Saskatchewan. Can J Public Health 98: 55–59.
|
| [26] | Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50: 1088–1101.
|
| [27] | Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629–634.
|
| [28] | R Development Core Team (2007) R: A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing. Available: http://www.R-project.org.
|
| [29] | StataCorp (2007) Stata Statistical Software: Release 10. College Station (Texas): StataCorp LP.
|
| [30] | Chen CH, Lian JD, Cheng CH, Wu MJ, Lee WC, et al. (2006) infection following renal transplantation in Taiwan. Transpl Infect Dis 8: 148–156.
|
| [31] | Brassard P, Kezouh A, Suissa S (2006) Antirheumatic drugs and the risk of tuberculosis. Clin Infect Dis 43: 717–722.
|
| [32] | John GT, Shankar V, Abraham AM, Mukundan U, Thomas PP, et al. (2001) Risk factors for post-transplant tuberculosis. Kidney Int 60: 1148–1153.
|
| [33] | Jick SS, Lieberman ES, Rahman MU, Choi HK (2006) Glucocorticoid use, other associated factors, and the risk of tuberculosis. Arthritis Rheum 55: 19–26.
|
| [34] | Mori MA, Leonardson G, Welty TK (1992) The benefits of isoniazid chemoprophylaxis and risk factors for tuberculosis among Oglala Sioux Indians. Arch Intern Med 152: 547–550.
|
| [35] | Buskin SE, Gale JL, Weiss NS, Nolan CM (1994) Tuberculosis risk factors in adults in King County, Washington, 1988 through 1990. Am J Public Health 84: 1750–1756.
|
| [36] | Rosenman KD, Hall N (1996) Occupational risk factors for developing tuberculosis. Am J Ind Med 30: 148–154.
|
| [37] | Coker R, McKee M, Atun R, Dimitrova B, Dodonova E, et al. (2006) Risk factors for pulmonary tuberculosis in Russia: case-control study. BMJ 332: 85–87.
|
| [38] | Lienhardt C, Fielding K, Sillah JS, Bah B, Gustafson P, et al. (2005) Investigation of the risk factors for tuberculosis: A case-control study in three countries in West Africa. Int J Epidemiol 34: 914–923.
|
| [39] | Mugusi F, Swai AB, Alberti KG, McLarty DG (1990) Increased prevalence of diabetes mellitus in patients with pulmonary tuberculosis in Tanzania. Tubercle 71: 271–276.
|
| [40] | Abe T, Iinuma Y, Ando M, Yokoyama T, Yamamoto T, et al. (2003) NRAMP1 polymorphisms, susceptibility and clinical features of tuberculosis. J Infect 46: 215–220.
|
| [41] | Al Kubaisy W, Al Dulayme A, Hashim DS (2003) Active tuberculosis among Iraqi schoolchildren with positive skin tests and their household contacts. East Mediterr Health J 9: 675–688.
|
| [42] | Tocque K, Bellis MA, Beeching NJ, Syed Q, Remmington T, et al. (2001) A case-control study of lifestyle risk factors associated with tuberculosis in Liverpool, North-West England. Eur Respir J 18: 959–964.
|
| [43] | Stevenson CR, Critchley JA, Forouhi NG, Roglic G, Williams BG, et al. (2007) Diabetes and the risk of tuberculosis: a neglected threat to public health. Chronic Illn 3: 228–245.
|
| [44] | World Health Organization (2000) WHO Global InfoBase. Mexico Encuesta Nacional de Salud 2000: tomo 2 la salud de los adultos. Available: http://www.who.int/infobase/reportviewer？.aspx?rptcode=ALL&uncode=484&dm=2&survey？code=101056a1. Accessed 12 March 2008.
|
| [45] | Lienhardt C, Rodrigues LC (1997) Estimation of the impact of the human immunodeficiency virus infection on tuberculosis: tuberculosis risks re-visited. Int J Tuberc Lung Dis 1: 196–204.
|
| [46] | UNAIDS (2007) AIDS epidemic update 2007. UNAIDS/07.27E / JC1322E. Available: http://data.unaids.org/pub/EPISlides/200？7/2007_epiupdate_en.pdf. Accessed 12 March 2008.
|
| [47] | Yamashiro S, Kwakami K, Uezu K, Kinjo T, Miyagi K, et al. (2005) Lower expression of Th1-related cytokines and inducible nitric oxide synthase in mice with streptozotocin-induced diabetes mellitus infected with . Clin Exp Immunol 139: 57–64.
|
| [48] | Martens GW, Arikan MC, Lee J, Ren F, Greiner D, et al. (2007) Tuberculosis susceptibility of diabetic mice. Am J Respir Cell Mol Biol 37: 518–524.
|
| [49] | Viardot A, Grey ST, Mackay F, Chisholm D (2007) Potential anti-inflammatory role of insulin via the preferential polarization of effector T cells toward a T helper 2 phenotype. Endocrinology 148: 346–353.
|
| [50] | Stalenhoef JE, Alisjahbana B, Nelwan EJ, van der Ven-Jongekrijg J, Ottenhoff THM, et al. (2008) The role of interferon-gamma in the increased tuberculosis risk in type 2 diabetes mellitus. Eur J Clin Microbiol Infect Dis 27: 97–103.
|
| [51] | Tsukaguchi K, Okamura H, Ikuno M, Kobayashi A, Fukuoka A, et al. (1997) [The relation between diabetes mellitus and IFN-gamma, IL-12 and IL-10 productions by CD4+ alpha beta T cells and monocytes in patients with pulmonary tuberculosis]. Kekkaku 72: 617–622.
|
| [52] | Delamaire M, Maugendre D, Moreno M, Le Goff MC, Allannic H, et al. (1997) Impaired Leucocyte functions in diabetic patients. Diabet Med 14: 29–34.
|
| [53] | Rayfield EJ, Ault MJ, Keusch GT, Brothers MJ, Nechemias C, et al. (1982) Infection and diabetes: The case for glucose control. Am J Med 72: 439–450.
|
| [54] | Feinstein AR, Walter SD, Horwitz RI (1986) An analysis of Berkson's bias in case-control studies. J Chron Dis 39: 495–504.
|
| [55] | Harris MI, Flegal KM, Cowie CC, Eberhardt MS, Goldstein DE, et al. (1998) Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. Adults: The Third National Health and Nutrition Examination Survey, 1988–1994. Diabetes Care 21: 518–524.
|
